Nyrada Inc. NYR.AX · Stock Open Nyrada Inc. in new tab
Nyrada Inc. Analysis (NYR.AX)
Is Nyrada Inc. a good investment? Nyrada Inc. (NYR.AX) is currently trading at 0.4800 AUD.
Earnings Schedule: Nyrada Inc. is expected to release its next earnings report on Feb. 16, 2026.
Investor FAQ
Does Nyrada Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Nyrada Inc.?
Nyrada Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Feb. 16, 2026. The company currently has a trailing EPS of -0.03.
Company Profile
Nyrada Inc., a clinical-stage biotechnology company, focuses on the discovery and development of small-molecule therapies for neuroprotection and cardioprotection indications in Australasia. Its lead candidate is Xolatryp, a small-molecule inhibitor targeting the transient receptor potential canonical ion channel subtypes 3, 6, and 7, which is in a Phase IIa clinical trial to treat myocardial ischemia, arrhythmia, stroke, and traumatic brain injury, as well as in a preclinical research stage for oncology indications. Nyrada Inc. was incorporated in 2017 and is based in Sydney, Australia.
Community Discussion